James J. Devlin
James J. Devlin publishes mostly in Genetics, Surgery and Molecular Biology, on topics such as Lipoproteins and Cardiovascular Health, Genetic Associations and Epidemiology and Diabetes, Cardiovascular Risks, and Lipoproteins.
- World rank
- #807,878 of 7,710,434 ranked researchers
- Rank in United States
- #269,333 of 1,627,098
- Works
- 157
- Citations
- 6.6k
- Citations per work
- 41.8
What does James J. Devlin research?
James J. Devlin's work is mostly in Medicine (23%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else8353.0%
- Life Sciences3823.9%
- Health Sciences3623.1%
- Medicine3623.1%
- 1Genetics10% of their works
- 2Surgery10% of their works
- 3Molecular Biology8% of their works
- 4Cardiology and Cardiovascular Medicine7% of their works
- 5Endocrinology, Diabetes and Metabolism6% of their works
- 6Immunology6% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Genetic Associations and Epidemiology
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Blood Coagulation and Thrombosis Mechanisms
- Protease and Inhibitor Mechanisms
- Health Systems, Economic Evaluations, Quality of Life
- Venous Thromboembolism Diagnosis and Management
- BRCA gene mutations in cancer
Which keywords describe James J. Devlin's research?
The keywords of their largest research topics: Cholesterol-lowering, Statins, Genetic Variation, Genome-Wide Association, Antithrombotic Therapy, Cardiovascular Disease, Metabolic Syndrome and Protease-Activated Receptors.
- BRCA1
- Pulmonary Embolism
- Quality of Life
- Cost-effectiveness Analysis
- Protease-Activated Receptors
- Cardiovascular Disease
- Genome-Wide Association
- Statins
- Cholesterol-lowering
- Genetic Variation
- Antithrombotic Therapy
- Metabolic Syndrome
- Thrombin
- Matrix Metalloproteinases
- Tissue Inhibitors of Metalloproteinases
- Venous Thromboembolism
- BRCA2
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Cholesterol-lowering311 topic
- Statins311 topic
- Genetic Variation241 topic
- Genome-Wide Association241 topic
- Antithrombotic Therapy162 topics
- Cardiovascular Disease131 topic
- Metabolic Syndrome131 topic
- Protease-Activated Receptors91 topic
- Thrombin91 topic
- Cost-effectiveness Analysis81 topic
- Matrix Metalloproteinases81 topic
- Quality of Life81 topic
- Tissue Inhibitors of Metalloproteinases81 topic
- Pulmonary Embolism71 topic
- Venous Thromboembolism71 topic
- BRCA161 topic
- BRCA261 topic
Where does James J. Devlin work?
James J. Devlin's main affiliation in the publication record is Quest Diagnostics (United States), United States.
How many publications and citations does James J. Devlin have?
OpenAlex counts 157 works and 6,559 citations for James J. Devlin, an h-index of 38, ranking #807,878 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about James J. Devlin. Posts are plain text and can be reported.